Share This Blog
- Luncheon with the Experts in New York City -- Carcinoid and Neuroendocrine Tumor Patients Are Invited!
- Carcinoid and Neuroendocrine Tumor Specialist Dr. Eugene A. Woltering Named Chair of AJCC Expert Panel
- A Possible Cure for Neuroendocrine Cancer: Exciting Update!
- But You Look So Good . . . Stories by Carcinoid Cancer Survivors
- FDA Approves Novel Radio-peptide Targeted Therapy Clinical Trial for Neuroendocrine Cancer: PRRT (Peptide Receptor Radionuclide Therapy)
- @a_swisstory sent you an email to connect with others in the #carcinoid #NETCancer community. Hope you got it! 4 days ago
- Do #doctors need guidance treating #NeuroendocrineCancer patients? Great online resource for physicians: bit.ly/1sNdaPg 5 days ago
- Recognizing great #cancer advocates on #FF: @teaminspire, @jangeissler, @myHEARTyrHANDS, @PLANETSCHARITY, @RareDiseases, @DominicNutt. 5 days ago
- @CarcinoidStory, we've learned more about how you connect with/create a group in Switzerland. Can you contact us via our website? 1 week ago
- Dr. Eugene Woltering named Chair of @AJCCancer Expert Panel on #NeuroendocrineTumors. bit.ly/1hXy0Xv http://t.co/aYBuQ52P27 1 week ago
Tag Archives: Dr. Joseph Herman
Carcinoid and neuroendocrine tumor patients and their families are invited to attend the 2012 NET Patient Half Day Conference on Sunday, January 22 in San Francisco, California. The latest developments in NET cancers, including clinical trials, recent drug approvals, imaging, … Continue reading